Product Recalls in California

Product recalls affecting California — including food, drugs, consumer products, medical devices, and vehicles distributed to California. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 3,072 recalls have been distributed to California in the last 12 months.

56,506 total recalls
3,072 in last 12 months

Showing 241260 of 13,703 recalls

DrugOctober 10, 2025· Alembic Pharmaceuticals Limited

Recalled Item: Fesoterodine Fumarate Recalled by Alembic Pharmaceuticals Limited Due to...

The Issue: Failed Impurities/Degradation Specifications: Due to levels of 'Diester...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 7.5mg Recalled by Endo USA, Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 2.5 mg Recalled by Endo USA, Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2025· QuVa Pharma, Inc.

Recalled Item: R.E.C.K. (Ropivacaine HCl Recalled by QuVa Pharma, Inc. Due to Presence of...

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 10 mg Recalled by Endo USA, Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2025· Endo USA, Inc.

Recalled Item: Everolimus tablets 5mg Recalled by Endo USA, Inc. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: Out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2025· Lannett Company Inc.

Recalled Item: Niacin Extended-release Tablets Recalled by Lannett Company Inc. Due to...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2025· The Harvard Drug Group LLC

Recalled Item: Gabapentin Capsules Recalled by The Harvard Drug Group LLC Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: an out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2025· The Harvard Drug Group LLC

Recalled Item: Gabapentin Capsules Recalled by The Harvard Drug Group LLC Due to Failed...

The Issue: Failed Impurities/Degradation Specifications: an out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2025· STAQ Pharma, Inc.

Recalled Item: Ketamine Hydrochloride Recalled by STAQ Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 9, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2025· USV Private Limited

Recalled Item: Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 % Recalled by USV...

The Issue: Failed Impurities/Degradation Specifications: The result for 'Any individual...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2025· Amerisource Health Services LLC

Recalled Item: Sucralfate Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: The recalling firm filed for Chapter 11 on September 30,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2025· STAQ Pharma, Inc.

Recalled Item: Hydromorphone HCL PF Recalled by STAQ Pharma, Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 9, 2025· STAQ Pharma, Inc.

Recalled Item: FentaNYL Citrate PF Recalled by STAQ Pharma, Inc. Due to Labeling: Incorrect...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 8, 2025· Mohamed Hagar

Recalled Item: Mojo Max Fusion XXX Recalled by Mohamed Hagar Due to Undeclared Sildenafil

The Issue: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 8, 2025· ASTRAZENECA PHARMACEUTICALS

Recalled Item: Fasenra (benralizumab) Injection Recalled by ASTRAZENECA PHARMACEUTICALS Due...

The Issue: Lack of Assurance of Sterility:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 7, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Prazosin Hydrochloride Recalled by Teva Pharmaceuticals USA, Inc Due to CGMP...

The Issue: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 7, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Prazosin Hydrochloride Recalled by Teva Pharmaceuticals USA, Inc Due to CGMP...

The Issue: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 7, 2025· Teva Pharmaceuticals USA, Inc

Recalled Item: Prazosin Hydrochloride Recalled by Teva Pharmaceuticals USA, Inc Due to CGMP...

The Issue: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund